Innovative contracting in Europe – a Trojan horse?Overview With pricing of drugs at the centre of political and social debate, the market access and pricing Share XInnovative contracting in Europe – a Trojan horse?https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/
How pharma marketing can stay ahead of the evolving customer journeyOverview View our webina which took place on Tuesday 23rd July at 16:00 BST / 11:00 EST / Share XHow pharma marketing can stay ahead of the evolving customer journeyhttps://pharmaphorum.com/digital/how-pharma-marketing-can-stay-ahead-of-the-evolving-customer-journey/
Orphan medicines launch excellence: sustaining launch successOverview Launching orphan medicines excellently will become even more important over the next five years as more patients Share XOrphan medicines launch excellence: sustaining launch successhttps://pharmaphorum.com/market-access-2/orphan-medicines-launch-excellence-sustaining-launch-success/
Navigating new frontiers: Ways to find space in the future RA marketOverview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
The 2nd Life Sciences Sector Deal and the NHS 10 Year PlanOverview Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK Share XThe 2nd Life Sciences Sector Deal and the NHS 10 Year Planhttps://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/
Metrics to meaning: demonstrating the value of medical communicationsOverview Medical affairs and publications teams are under increasing pressure to demonstrate effectively the success of the medical Share XMetrics to meaning: demonstrating the value of medical communicationshttps://pharmaphorum.com/sales-marketing/metrics-to-meaning-demonstrating-the-value-of-medical-communications/
The devil’s in the e-detail: what HCPs really want from youOverview Communication; we all do it, it is a critical part of effective business practice and in this Share XThe devil’s in the e-detail: what HCPs really want from youhttps://pharmaphorum.com/digital/the-devils-in-the-e-detail-what-hcps-really-want-from-you/
Can simulated datasets unlock the potential of patient data?Overview Patient level data offers the promise of insights which can craft new and better pathways, enable development Share XCan simulated datasets unlock the potential of patient data?https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/
Realising the biotech promise: addressing the path to marketOverview Now more than ever before, biotech is the engine for innovation in medicine, finding, creating and delivering Share XRealising the biotech promise: addressing the path to markethttps://pharmaphorum.com/market-access-2/addressing-the-path-to-market/
